Earnings History Data for GlycoMimetics, Inc. (GLYC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
GlycoMimetics, Inc.
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-05-2024 | PM | GLYC | GlycoMimetics, Inc. | 19.68 | -0.17 | -0.16 | -0.17 | 0.2994 | 0.0 (0.34%) |
0.32 | 0.02 (5.63%) |
0.27 - 3.53 | 2,184,723 | 5,880,000 | 531,868 | |||
| 27-03-2024 | PM | GLYC | GlycoMimetics, Inc. | 181.59 | -0.14 | -0.15 | -0.19 | GlycoMimetics GAAP EPS of -$0.14 beats by $0.01 [3/27/2024 7:08 AM] |
3.14 | 0.29 (10.18%) |
3.00 | 0.15 (5.26%) |
1.11 - 3.53 | 583,473 | 340,000 | 26,291 | ||
| 03-11-2023 | PM | GLYC | GlycoMimetics, Inc. | 80.40 | -0.14 | -0.14 | -0.16 | GlycoMimetics GAAP EPS of -$0.14 in-line [11/3/2023 7:11 AM] |
1.35 | 0.06 (4.65%) |
1.37 | 0.08 (6.20%) |
0.66 - 4.16 | 188,779 | 140,000 | 8,622 | ||
| 02-08-2023 | PM | GLYC | GlycoMimetics, Inc. | 105.36 | -0.13 | -0.18 | -0.25 | GlycoMimetics Non-GAAP EPS of -$0.13 beats by $0.04 [8/2/2023 7:06 AM] |
1.58 | -0.07 (-4.24%) |
1.65 | 0.0 (0.00%) |
0.55 - 4.16 | 183,544 | 110,000 | 1,257 | ||
| 03-05-2023 | PM | 7:00 AM ET (May 3) |
GLYC | GlycoMimetics, Inc. | 91.87 | -0.17 | -0.17 | -0.28 | GlycoMimetics GAAP EPS of -$0.17 in-line [5/3/2023 7:21 AM] |
1.36 | -0.05 (-3.55%) |
1.39 | -0.02 (-1.42%) |
0.51 - 4.16 | 173,342 | 130,000 | 737 | |
| 29-03-2023 | PM | 7:00 AM ET (Mar 29) |
GLYC | GlycoMimetics | 73.00 | -0.19 | -0.17 | 0.00 | GlycoMimetics GAAP EPS of -$0.19 misses by $0.02 [3/29/2023 7:04 AM] |
1.25 | -0.15 (-10.36%) |
1.37 | -0.03 (-2.14%) |
0.51 - 4.16 | 1,031,143 | 270,000 | 17,061 | |
| 09-11-2022 | PM | 7:00 AM ET (Nov 9) |
GLYC | GlycoMimetics, Inc. | 35.71 | -0.16 | -0.26 | -0.34 | GlycoMimetics GAAP EPS of -$0.16 beats by $0.10 [11/9/2022 7:13 AM] |
0.8101 | 0.12 (17.85%) |
0.69 | 0.0 (0.38%) |
0.51 - 2.26 | 475,236 | 70,000 | 23,688 | |
| 03-08-2022 | PM | 7:30 AM ET (Aug 3) |
GLYC | GlycoMimetics, Inc. | 37.53 | -0.25 | -0.28 | -0.28 | GlycoMimetics GAAP EPS of $0.25 beats by $0.53, revenue of $75K [8/3/2022 7:14 AM] |
0.7173 | 0.05 (6.74%) |
0.71 | 0.04 (5.65%) |
0.51 - 2.50 | 137,226 | 70,000 | 14,316 | |
| 28-04-2022 | PM | 7:30 AM ET (Apr 28) |
GLYC | GlycoMimetics, Inc. | 46.07 | -0.28 | -0.31 | -0.28 | GlycoMimetics GAAP EPS of -$0.28 beats by $0.03 [4/28/2022 7:43 AM] |
0.7960 | -0.04 (-5.25%) |
0.0 | 0.0 (0.00%) |
0.75 - 2.83 | 507,738 | 190,000 | 0 | |
| 03-03-2022 | PM | 7:30 AM ET (Mar 3) |
GLYC | GlycoMimetics, Inc. | 63.64 | -0.33 | -0.31 | -0.32 | GlycoMimetics GAAP EPS of -$0.33 beats by $0.01, revenue of $0.18M [3/3/2022 7:33 AM] |
1.17 | -0.19 (-13.97%) |
1.37 | 0.01 (0.74%) |
1.01 - 3.62 | 206,089 | 260,000 | 500 | |
|
||||||||||||||||||
| 02-11-2021 | PM | 7:30 AM ET (Nov 2) |
GLYC | GlycoMimetics, Inc. | 97.41 | -0.34 | -0.32 | -0.29 | GlycoMimetics reports Q3 results [11/2/2021 10:10 AM] |
2.05 | 0.05 (2.50%) |
2.05 | 0.0 (0.00%) |
1.78 - 4.40 | 222,023 | 260,000 | 347 | |
| 05-08-2021 | PM | 7:30 AM ET (Aug 5) |
GLYC | GlycoMimetics, Inc. | 104.11 | -0.28 | -0.31 | -0.32 | GlycoMimetics EPS beats by $0.03 [8/5/2021 7:42 AM] |
2.15 | 0.18 (9.14%) |
1.98 | 0.01 (0.51%) |
1.92 - 4.40 | 595,284 | 210,000 | 20,256 | |
|
||||||||||||||||||
| 03-05-2021 | PM | 7:30 AM ET (May 3) |
GLYC | GlycoMimetics, Inc. | 129.88 | -0.28 | -0.32 | -0.18 | GlycoMimetics EPS beats by $0.04 [5/3/2021 7:33 AM] |
2.39 | -0.01 (-0.42%) |
2.39 | -0.01 (-0.42%) |
2.31 - 5.19 | 616,786 | 450,000 | 17,397 | |
|
||||||||||||||||||
| 02-03-2021 | PM | 7:30 AM ET (Mar 2) |
GLYC | GlycoMimetics, Inc. | 158.79 | -0.32 | -0.32 | -0.34 | GlycoMimetics EPS in-line, misses on revenue [3/2/2021 7:32 AM] |
3.25 | -0.34 (-9.47%) |
3.50 | -0.09 (-2.51%) |
1.82 - 5.19 | 1,848,932 | 1,001,552 | 73,136 | |
| 06-11-2020 | PM | 8:00 AM ET (Nov 6) |
GLYC | GlycoMimetics, Inc. | 141.27 | -0.29 | -0.33 | -0.31 | GlycoMimetics EPS beats by $0.04 [11/6/2020 7:31 AM] |
2.99 | -0.06 (-1.97%) |
3.05 | 0.0 (0.00%) |
1.82 - 6.72 | 404,550 | 805,666 | 49,978 | |
|
|
||||||||||||||||||
| 31-07-2020 | PM | 4:05 PM ET (Jul 31) |
GLYC | GlycoMimetics, Inc. | 186.97 | -0.32 | -0.37 | -0.37 | GlycoMimetics EPS beats by $0.06 [7/31/2020 8:29 AM] |
3.95 | -0.20 (-4.82%) |
4.40 | 0.25 (6.02%) |
1.82 - 9.53 | 363,550 | 746,789 | 7,548 | |
|
|
||||||||||||||||||